Alpha Tau Medical Ltd. (DRTS) has a MoatMap StockRank of 54/100 based on Quality (33/100), Value (35/100), and Momentum (71/100) factor scores. The current signal is HOLD.
Alpha Tau Medical Ltd. is a clinical-stage oncology company developing Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), an innovative treatment for solid tumors using localized alpha-radiation. The company's proprietary technology directly targets tumors with high-energy alpha particles, aiming for potent and precise tumor destruction with minimal impact on surrounding healthy tissue. Alpha Tau Medical holds a unique position in oncology by advancing a differentiated alpha-radiation therapy for a broad range of cancers.
| Price | $10.04 |
| Market Cap | $907M |
| P/E (Forward) | -21.63 |
| Price/Book | 13.42 |
| Return on Equity | -90.5% |
| Return on Invested Capital | -44.3% |
| Debt/Equity | 20.68 |
| Gross Margin | 0.0% |
| Operating Margin | 0.0% |
Alpha Tau Medical Ltd. operates in the Biotechnology industry, part of the Healthcare sector (Israel).